Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by steadfaston Apr 09, 2021 2:10pm
140 Views
Post# 32967802

HOW TO NEGOTIATE A BOT DEAL - take a lesson from Adventus Mi

HOW TO NEGOTIATE A BOT DEAL - take a lesson from Adventus MiADZN - July 14  $1.60  high
           July 28   $1.38 NR re Bot deal  @ $1.27  NO WARRANTS
           Aug 14   $1.18 Close Bot deal on schedule

Done with Raymond James, Haywood & National Bank
27,559,100 common shares @ $1.27 gross proceeds $35,000,057
Allowed overallotment option 4,133,865 M common shares
Underwriter's received a cash commission equal to 5.5% of gross proceeds,
which commission was reduced to 2.75%

Does anyone have a Well negotiated  Bot deal they would like to share.
Note:  Raymond James & National Bank have been supporters of SVA over the yrs
<< Previous
Bullboard Posts
Next >>